Advanced Solid Tumor
5 competing products in clinical development for Advanced Solid Tumor.
Pipeline by Phase
Phase 12
Phase 1/23
All Products (5)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| LY3499446 + Abemaciclib + Cetuximab + Erlotinib + Docetaxel | Eli Lilly | Phase 1/2 | Terminated | 41 |
| SON-1010 | Sonnet BioTherapeutics | Phase 1/2 | Terminated | 36 |
| AFM24 + Atezolizumab 840 MG in 14 ML Injection | Affimed | Phase 1/2 | Terminated | 33 |
| SON-1010 | Sonnet BioTherapeutics | Phase 1 | Active | 28 |
| BBP-398 | LianBio | Phase 1 | Terminated | 25 |